10-K Decoder · All companies

Pacira BioSciences, Inc.

PCRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$726M$701M+3.6%
Operating income$19.2M−$73.4M
Net income$7.03M−$99.6M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$177M$180M−1.6%
Operating income$22.3M$6.40M+248%
Net income$28.5M$5.40M+428%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Pacira's revenue in FY2025?
$726M in FY2025 (Fiscal year ended Dec 31, 2025), +3.6% vs $701M a year earlier, per its 10-K filed Feb 2026.
Was Pacira profitable in FY2025?
Yes: net income was $7.03M and operating income $19.2M in FY2025.
What was Pacira's revenue in Q3 2026?
$177M (−1.6% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.